nodes	percent_of_prediction	percent_of_DWPC	metapath
Lumiracoxib—PTGS2—Triamcinolone—multiple sclerosis	0.302	0.327	CbGbCtD
Lumiracoxib—PTGS2—Betamethasone—multiple sclerosis	0.259	0.281	CbGbCtD
Lumiracoxib—PTGS2—Dexamethasone—multiple sclerosis	0.151	0.163	CbGbCtD
Lumiracoxib—CYP2C19—Prednisone—multiple sclerosis	0.0988	0.107	CbGbCtD
Lumiracoxib—CYP2C19—Dexamethasone—multiple sclerosis	0.0617	0.0667	CbGbCtD
Lumiracoxib—CYP2C9—Dexamethasone—multiple sclerosis	0.0513	0.0555	CbGbCtD
Lumiracoxib—PTGS2—Fluocinonide—Methylprednisolone—multiple sclerosis	0.00227	0.159	CbGdCrCtD
Lumiracoxib—PTGS2—Fluocinonide—Betamethasone—multiple sclerosis	0.00223	0.156	CbGdCrCtD
Lumiracoxib—PTGS2—Fluocinonide—Dexamethasone—multiple sclerosis	0.00223	0.156	CbGdCrCtD
Lumiracoxib—PTGS2—Fluocinonide—Triamcinolone—multiple sclerosis	0.00218	0.153	CbGdCrCtD
Lumiracoxib—PTGS2—Fluticasone Propionate—Methylprednisolone—multiple sclerosis	0.00137	0.0957	CbGdCrCtD
Lumiracoxib—PTGS2—Fluticasone Propionate—Betamethasone—multiple sclerosis	0.00135	0.0942	CbGdCrCtD
Lumiracoxib—PTGS2—Fluticasone Propionate—Dexamethasone—multiple sclerosis	0.00135	0.0942	CbGdCrCtD
Lumiracoxib—PTGS2—Fluticasone Propionate—Triamcinolone—multiple sclerosis	0.00132	0.0921	CbGdCrCtD
Lumiracoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TBX21—multiple sclerosis	0.00114	0.0187	CbGpPWpGaD
Lumiracoxib—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.00103	0.0168	CbGpPWpGaD
Lumiracoxib—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.00103	0.0168	CbGpPWpGaD
Lumiracoxib—PTGS1—Prostaglandin Synthesis and Regulation—PTGER4—multiple sclerosis	0.00103	0.0168	CbGpPWpGaD
Lumiracoxib—PTGS1—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.00101	0.0165	CbGpPWpGaD
Lumiracoxib—PTGS1—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.00101	0.0165	CbGpPWpGaD
Lumiracoxib—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000878	0.0144	CbGpPWpGaD
Lumiracoxib—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000878	0.0144	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CBLB—multiple sclerosis	0.000836	0.0137	CbGpPWpGaD
Lumiracoxib—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	0.000819	0.0134	CbGpPWpGaD
Lumiracoxib—PTGS2—Prostaglandin Synthesis and Regulation—PTGER4—multiple sclerosis	0.000815	0.0133	CbGpPWpGaD
Lumiracoxib—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000715	0.0117	CbGpPWpGaD
Lumiracoxib—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000715	0.0117	CbGpPWpGaD
Lumiracoxib—CYP2C19—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000706	0.0116	CbGpPWpGaD
Lumiracoxib—CYP2C19—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000706	0.0116	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—multiple sclerosis	0.000678	0.0111	CbGpPWpGaD
Lumiracoxib—UGT1A9—Biological oxidations—CYP27B1—multiple sclerosis	0.000655	0.0107	CbGpPWpGaD
Lumiracoxib—UGT1A9—Biological oxidations—CYP24A1—multiple sclerosis	0.000655	0.0107	CbGpPWpGaD
Lumiracoxib—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000652	0.0107	CbGpPWpGaD
Lumiracoxib—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000652	0.0107	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000646	0.0106	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000646	0.0106	CbGpPWpGaD
Lumiracoxib—CYP2C9—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000644	0.0105	CbGpPWpGaD
Lumiracoxib—CYP2C9—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000644	0.0105	CbGpPWpGaD
Lumiracoxib—CYP2C19—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.00058	0.00949	CbGpPWpGaD
Lumiracoxib—CYP2C19—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.00058	0.00949	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—multiple sclerosis	0.000561	0.00918	CbGpPWpGaD
Lumiracoxib—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000557	0.00912	CbGpPWpGaD
Lumiracoxib—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000557	0.00912	CbGpPWpGaD
Lumiracoxib—CYP1A2—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.00055	0.009	CbGpPWpGaD
Lumiracoxib—CYP1A2—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.00055	0.009	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—multiple sclerosis	0.000546	0.00893	CbGpPWpGaD
Lumiracoxib—PTGS1—Biological oxidations—CYP27B1—multiple sclerosis	0.000534	0.00875	CbGpPWpGaD
Lumiracoxib—PTGS1—Biological oxidations—CYP24A1—multiple sclerosis	0.000534	0.00875	CbGpPWpGaD
Lumiracoxib—CYP2C9—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000529	0.00866	CbGpPWpGaD
Lumiracoxib—CYP2C9—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000529	0.00866	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—multiple sclerosis	0.0005	0.00818	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—MBP—multiple sclerosis	0.000488	0.00798	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—multiple sclerosis	0.000478	0.00782	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—multiple sclerosis	0.000466	0.00763	CbGpPWpGaD
Lumiracoxib—CYP1A2—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000452	0.0074	CbGpPWpGaD
Lumiracoxib—CYP1A2—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000452	0.0074	CbGpPWpGaD
Lumiracoxib—UGT1A9—PPAR Alpha Pathway—MYC—multiple sclerosis	0.000386	0.00632	CbGpPWpGaD
Lumiracoxib—PTGS1—Overview of nanoparticle effects—TNF—multiple sclerosis	0.000377	0.00617	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—AQP4—multiple sclerosis	0.000369	0.00605	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—multiple sclerosis	0.000363	0.00594	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—multiple sclerosis	0.000353	0.00578	CbGpPWpGaD
Lumiracoxib—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	0.000352	0.00577	CbGpPWpGaD
Lumiracoxib—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000336	0.0055	CbGpPWpGaD
Lumiracoxib—CYP2C19—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000335	0.00549	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—multiple sclerosis	0.00033	0.0054	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—multiple sclerosis	0.000323	0.00529	CbGpPWpGaD
Lumiracoxib—PTGS2—S1P1 pathway—MAPK1—multiple sclerosis	0.000314	0.00515	CbGpPWpGaD
Lumiracoxib—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	0.000314	0.00514	CbGpPWpGaD
Lumiracoxib—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	0.000313	0.00512	CbGpPWpGaD
Lumiracoxib—CYP2C19—Biological oxidations—CYP24A1—multiple sclerosis	0.000308	0.00504	CbGpPWpGaD
Lumiracoxib—CYP2C19—Biological oxidations—CYP27B1—multiple sclerosis	0.000308	0.00504	CbGpPWpGaD
Lumiracoxib—PTGS1—Overview of nanoparticle effects—IL6—multiple sclerosis	0.000304	0.00498	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000304	0.00497	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000304	0.00497	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	0.0003	0.00491	CbGpPWpGaD
Lumiracoxib—PTGS2—Overview of nanoparticle effects—TNF—multiple sclerosis	0.000299	0.0049	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.000296	0.00484	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—multiple sclerosis	0.000293	0.0048	CbGpPWpGaD
Lumiracoxib—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000287	0.0047	CbGpPWpGaD
Lumiracoxib—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	0.000281	0.0046	CbGpPWpGaD
Lumiracoxib—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	0.000281	0.0046	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000277	0.00453	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000277	0.00453	CbGpPWpGaD
Lumiracoxib—CYP1A2—Estrogen Receptor Pathway—STAT3—multiple sclerosis	0.000265	0.00434	CbGpPWpGaD
Lumiracoxib—CYP1A2—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000261	0.00427	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—CCR2—multiple sclerosis	0.000256	0.00419	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000252	0.00412	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000252	0.00412	CbGpPWpGaD
Lumiracoxib—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	0.000244	0.004	CbGpPWpGaD
Lumiracoxib—PTGS2—Overview of nanoparticle effects—IL6—multiple sclerosis	0.000242	0.00395	CbGpPWpGaD
Lumiracoxib—CYP1A2—Biological oxidations—CYP24A1—multiple sclerosis	0.00024	0.00393	CbGpPWpGaD
Lumiracoxib—CYP1A2—Biological oxidations—CYP27B1—multiple sclerosis	0.00024	0.00393	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000237	0.00387	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000237	0.00387	CbGpPWpGaD
Lumiracoxib—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	0.000228	0.00373	CbGpPWpGaD
Lumiracoxib—PTGS1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000226	0.0037	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—ICAM1—multiple sclerosis	0.000225	0.00368	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—multiple sclerosis	0.000213	0.00349	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—CXCL10—multiple sclerosis	0.000213	0.00348	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000205	0.00336	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000205	0.00336	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—CCL2—multiple sclerosis	0.000201	0.00329	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—BDNF—multiple sclerosis	0.000191	0.00313	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—multiple sclerosis	0.00019	0.0031	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—ALB—multiple sclerosis	0.000187	0.00307	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—ICAM1—multiple sclerosis	0.000178	0.00292	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—IL4—multiple sclerosis	0.000178	0.00291	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—IFNG—multiple sclerosis	0.000171	0.0028	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000163	0.00267	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000163	0.00267	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	0.000162	0.00265	CbGpPWpGaD
Lumiracoxib—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000161	0.00263	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—CCL2—multiple sclerosis	0.00016	0.00261	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—SRM—multiple sclerosis	0.000159	0.0026	CbGpPWpGaD
Lumiracoxib—PTGS2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	0.000158	0.00259	CbGpPWpGaD
Lumiracoxib—PTGS2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	0.000155	0.00254	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—IL1B—multiple sclerosis	0.000152	0.0025	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—ALB—multiple sclerosis	0.000149	0.00243	CbGpPWpGaD
Lumiracoxib—PTGS2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	0.000148	0.00242	CbGpPWpGaD
Lumiracoxib—UGT1A9—Biological oxidations—POMC—multiple sclerosis	0.000147	0.00241	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—TLR4—multiple sclerosis	0.000147	0.00241	CbGpPWpGaD
Lumiracoxib—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000147	0.0024	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—ICAM1—multiple sclerosis	0.000141	0.00231	CbGpPWpGaD
Lumiracoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—multiple sclerosis	0.000138	0.00226	CbGpPWpGaD
Lumiracoxib—PTGS2—C-MYB transcription factor network—CD4—multiple sclerosis	0.000136	0.00223	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—IFNG—multiple sclerosis	0.000136	0.00222	CbGpPWpGaD
Lumiracoxib—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.00013	0.00214	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	0.00013	0.00213	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—SRM—multiple sclerosis	0.00013	0.00212	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	0.000129	0.00211	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—CCL2—multiple sclerosis	0.000126	0.00207	CbGpPWpGaD
Lumiracoxib—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000125	0.00205	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—IL1B—multiple sclerosis	0.000121	0.00198	CbGpPWpGaD
Lumiracoxib—PTGS1—Biological oxidations—POMC—multiple sclerosis	0.00012	0.00197	CbGpPWpGaD
Lumiracoxib—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000119	0.00195	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000118	0.00194	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000118	0.00194	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	0.000115	0.00188	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	0.000115	0.00188	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—CYP27B1—multiple sclerosis	0.000112	0.00183	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—CYP24A1—multiple sclerosis	0.000112	0.00183	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	0.000111	0.00182	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—TNF—multiple sclerosis	0.000111	0.00181	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.00011	0.00179	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000108	0.00177	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000108	0.00177	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—IFNG—multiple sclerosis	0.000107	0.00176	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—SRM—multiple sclerosis	0.000103	0.00169	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—GPC5—multiple sclerosis	0.000103	0.00168	CbGpPWpGaD
Lumiracoxib—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000102	0.00166	CbGpPWpGaD
Lumiracoxib—PTGS2—C-MYB transcription factor network—MYC—multiple sclerosis	9.79e-05	0.0016	CbGpPWpGaD
Lumiracoxib—UGT1A9—NRF2 pathway—TGFB1—multiple sclerosis	9.69e-05	0.00159	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—IL1B—multiple sclerosis	9.57e-05	0.00157	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—IL2—multiple sclerosis	9.54e-05	0.00156	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	9.22e-05	0.00151	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	9.22e-05	0.00151	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—CYP27B1—multiple sclerosis	9.14e-05	0.0015	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—CYP24A1—multiple sclerosis	9.14e-05	0.0015	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—MMP9—multiple sclerosis	9.02e-05	0.00148	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	8.96e-05	0.00147	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	8.94e-05	0.00146	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	8.93e-05	0.00146	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—IL6—multiple sclerosis	8.93e-05	0.00146	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—TNF—multiple sclerosis	8.78e-05	0.00144	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	8.77e-05	0.00144	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—RRM1—multiple sclerosis	8.49e-05	0.00139	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—GPC5—multiple sclerosis	8.36e-05	0.00137	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	8.35e-05	0.00137	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	8.35e-05	0.00137	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—GPC5—multiple sclerosis	7.92e-05	0.0013	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—SRM—multiple sclerosis	7.48e-05	0.00122	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—MYC—multiple sclerosis	7.46e-05	0.00122	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—TGFB1—multiple sclerosis	7.44e-05	0.00122	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—MAPK1—multiple sclerosis	7.29e-05	0.00119	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—CYP27B1—multiple sclerosis	7.25e-05	0.00119	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—CYP24A1—multiple sclerosis	7.25e-05	0.00119	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	7.09e-05	0.00116	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—IL6—multiple sclerosis	7.09e-05	0.00116	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—TNF—multiple sclerosis	6.95e-05	0.00114	CbGpPWpGaD
Lumiracoxib—CYP2C19—Biological oxidations—POMC—multiple sclerosis	6.93e-05	0.00113	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—RRM1—multiple sclerosis	6.92e-05	0.00113	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—SRM—multiple sclerosis	6.82e-05	0.00112	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—GPC5—multiple sclerosis	6.63e-05	0.00109	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	6.59e-05	0.00108	CbGpPWpGaD
Lumiracoxib—CYP2C9—Biological oxidations—POMC—multiple sclerosis	6.32e-05	0.00103	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—SRM—multiple sclerosis	5.83e-05	0.000954	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	5.66e-05	0.000927	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—IL6—multiple sclerosis	5.6e-05	0.000917	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—RRM1—multiple sclerosis	5.5e-05	0.0009	CbGpPWpGaD
Lumiracoxib—CYP1A2—Biological oxidations—POMC—multiple sclerosis	5.4e-05	0.000884	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	5.37e-05	0.000879	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	5.27e-05	0.000862	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	5.27e-05	0.000862	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	5.16e-05	0.000845	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—RPL5—multiple sclerosis	5.15e-05	0.000843	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	5.15e-05	0.000843	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	5.07e-05	0.00083	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	5.06e-05	0.000828	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	4.96e-05	0.000812	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—SLC11A1—multiple sclerosis	4.93e-05	0.000808	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—BCHE—multiple sclerosis	4.88e-05	0.000799	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—GPC5—multiple sclerosis	4.82e-05	0.000789	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	4.8e-05	0.000786	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	4.8e-05	0.000786	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	4.72e-05	0.000773	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.69e-05	0.000768	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	4.62e-05	0.000755	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—GPC5—multiple sclerosis	4.39e-05	0.000719	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	4.26e-05	0.000698	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4.21e-05	0.000689	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	4.1e-05	0.000672	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	4.1e-05	0.000672	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.01e-05	0.000657	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—RRM1—multiple sclerosis	3.99e-05	0.000653	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—BCHE—multiple sclerosis	3.98e-05	0.000651	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CD28—multiple sclerosis	3.94e-05	0.000645	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—GPC5—multiple sclerosis	3.75e-05	0.000615	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.66e-05	0.0006	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—RRM1—multiple sclerosis	3.64e-05	0.000596	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.34e-05	0.000547	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—BCHE—multiple sclerosis	3.16e-05	0.000517	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—RRM1—multiple sclerosis	3.11e-05	0.000509	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.1e-05	0.000507	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—APOE—multiple sclerosis	2.94e-05	0.00048	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.82e-05	0.000462	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CD86—multiple sclerosis	2.81e-05	0.00046	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.66e-05	0.000436	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—POMC—multiple sclerosis	2.52e-05	0.000413	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CCR5—multiple sclerosis	2.49e-05	0.000408	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—HLA-A—multiple sclerosis	2.43e-05	0.000398	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.43e-05	0.000397	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.43e-05	0.000397	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.41e-05	0.000395	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—APOE—multiple sclerosis	2.39e-05	0.000392	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—ALB—multiple sclerosis	2.3e-05	0.000376	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—BCHE—multiple sclerosis	2.29e-05	0.000375	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—APOE—multiple sclerosis	2.27e-05	0.000371	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.21e-05	0.000362	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—BCHE—multiple sclerosis	2.09e-05	0.000342	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.07e-05	0.000339	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—POMC—multiple sclerosis	2.06e-05	0.000336	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CD80—multiple sclerosis	2.05e-05	0.000336	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—APOE—multiple sclerosis	1.9e-05	0.000311	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.89e-05	0.000309	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—ALB—multiple sclerosis	1.87e-05	0.000307	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—BCHE—multiple sclerosis	1.79e-05	0.000292	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—TYK2—multiple sclerosis	1.73e-05	0.000283	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—POMC—multiple sclerosis	1.63e-05	0.000267	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CD4—multiple sclerosis	1.57e-05	0.000256	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—ALB—multiple sclerosis	1.49e-05	0.000243	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—APOE—multiple sclerosis	1.38e-05	0.000226	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—APOE—multiple sclerosis	1.26e-05	0.000206	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—STAT3—multiple sclerosis	1.21e-05	0.000198	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—POMC—multiple sclerosis	1.19e-05	0.000194	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—MYC—multiple sclerosis	1.13e-05	0.000184	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—TGFB1—multiple sclerosis	1.12e-05	0.000184	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—MAPK1—multiple sclerosis	1.1e-05	0.00018	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—POMC—multiple sclerosis	1.08e-05	0.000177	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—ALB—multiple sclerosis	1.08e-05	0.000177	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—APOE—multiple sclerosis	1.07e-05	0.000176	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—ALB—multiple sclerosis	9.85e-06	0.000161	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—POMC—multiple sclerosis	9.23e-06	0.000151	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—IL6—multiple sclerosis	8.47e-06	0.000139	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ALB—multiple sclerosis	8.42e-06	0.000138	CbGpPWpGaD
